Sphere Fluidics Strengthens Global Commercial Teams and Establishes Direct Sales and Support Channel in North America [Yahoo! Finance]
10x Genomics, Inc. (TXG)
Last 10x genomics, inc. earnings: 2/18 04:01 pm
Check Earnings Report
Company Research
Source: Yahoo! Finance
CAMBRIDGE, England, November 14, 2024 BUSINESS WIRE )--Sphere Fluidics, a leading provider of innovative droplet-based microfluidics solutions for functional profiling of single cells at scale, today announced a significant expansion of its global commercial presence. The Company has established a new direct sales and support channel for customers in North America and made several commercial leadership changes globally. These milestones reflect the ongoing strategic focus on operational scale-up to address demand for the Company's Cyto-Mine ® platform and provide local specialized support. As North America Commercial Director, Dr. Erroll Rueckert has joined to lead a new and rapidly expanding sales team for the American market. Central to this role is building a new direct sales channel in this key region, streamlining customer access to its portfolio of products, including the recently announced Cyto-Mine Chroma platform . Erroll has strong commercial and technical expertise in si
Show less
Read more
Impact Snapshot
Event Time:
TXG
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
TXG alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
TXG alerts
High impacting 10x Genomics, Inc. news events
Weekly update
A roundup of the hottest topics
TXG
News
- 10x Genomics to Present at the Wolfe Research 2024 Healthcare ConferencePR Newswire
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Barclays PLC from $21.00 to $19.00. They now have an "overweight" rating on the stock.MarketBeat
- Earnings Update: 10x Genomics, Inc. (NASDAQ:TXG) Just Reported And Analysts Are Trimming Their Forecasts [Yahoo! Finance]Yahoo! Finance
- TechBio Startup Cure51 Selects 10x Genomics Visium HD for New Drug Discovery InitiativePR Newswire
- 10x Genomics, Inc. (NASDAQ: TXG) had its price target lowered by analysts at Citigroup Inc. from $35.00 to $23.00. They now have a "buy" rating on the stock.MarketBeat
TXG
Earnings
- 10/29/24 - Beat
TXG
Sec Filings
- 11/8/24 - Form SC
- 11/5/24 - Form SC
- 10/29/24 - Form 10-Q
- TXG's page on the SEC website